Evaluation of targeted screening in high risk melanoma patients using: 3D full body imaging, genomic risk assessment and functional testing of gene variants.
- Conditions
- MelanomaSkin - Other skin conditionsCancer - Malignant melanoma
- Registration Number
- ACTRN12618000267257
- Lead Sponsor
- The University of Queensland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 314
1st round of recruitment:
- diagnosed with multiple melanomas before the age of 40
2nd round of recruitment:
- aged 40-65 with multiple melanomas
3rd round of recruitment:
- diagnosed with single melanoma before the age of 40
4th round of recruitment;
- Individuals considered high risk by a Dermatologist due to strong family history of melanoma, genetic status, and/or dysplastic naevi syndrome
The different inclusion criteria at different rounds of recruitment are to ensure that those at highest risk to melanoma are given the opportunity to participate in the study.
Other inclusion criteria includes:
-ability to provide informed consent
-willingness and ability to commit to a 24 months study including attending 5 visits to the CRF facility at Princess Alexandra Hospital
Receiving current treatment for melanoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method